142 related articles for article (PubMed ID: 2876493)
1. The role of somatostatin and a long-acting analogue, SMS 201-995, in acute bleeding due to peptic ulceration.
Christiansen J; Yotis A
Scand J Gastroenterol Suppl; 1986; 119():109-14. PubMed ID: 2876493
[TBL] [Abstract][Full Text] [Related]
2. Somatostatin and its analogues in peptic ulcer bleeding: facts and pathophysiological aspects.
Sgouros SN; Bergele C; Viazis N; Avgerinos A
Dig Liver Dis; 2006 Feb; 38(2):143-8. PubMed ID: 16005698
[TBL] [Abstract][Full Text] [Related]
3. Treatment of relapsing bleeding peptic ulcers with the somatostatin analogue SMS 201 995 in a patient with Zollinger-Ellison syndrome.
Wörmann B; Kutz K; Ottenjann R
Hepatogastroenterology; 1985 Jun; 32(3):152-3. PubMed ID: 2862099
[TBL] [Abstract][Full Text] [Related]
4. Placebo-controlled trial with the somatostatin analogue SMS 201-995 in peptic ulcer bleeding.
Christiansen J; Ottenjann R; Von Arx F
Gastroenterology; 1989 Sep; 97(3):568-74. PubMed ID: 2666249
[TBL] [Abstract][Full Text] [Related]
5. Secretin and somatostatin in the treatment of upper gastrointestinal haemorrhage.
Magnusson I
Scand J Gastroenterol Suppl; 1987; 137():56-60. PubMed ID: 2892264
[TBL] [Abstract][Full Text] [Related]
6. Somatostatin in peptic ulcer bleeding--results of a double-blind controlled trial.
Galmiche JP; Cassigneul J; Faivre J; Tranvouez JL; Ouvry D; Colin R; Pascal JP; Klepping C
Int J Clin Pharmacol Res; 1983; 3(5):379-87. PubMed ID: 6147315
[TBL] [Abstract][Full Text] [Related]
7. Management of massive upper gastrointestinal haemorrhage from multiple sites of peptic ulceration with somatostatin and octreotide--a report of five cases.
Jenkins SA; Taylor BA; Nott DM; Ellenbogen S; Haggie J; Shields R
Gut; 1992 Mar; 33(3):404-7. PubMed ID: 1348999
[TBL] [Abstract][Full Text] [Related]
8. Somatostatin reduces gastric mucosal blood flow in normal subjects but not in patients with cirrhosis of the liver.
Sonnenberg A; West C
Gut; 1983 Feb; 24(2):148-53. PubMed ID: 6133813
[TBL] [Abstract][Full Text] [Related]
9. Somatostatin in the treatment of severe gastrointestinal bleeding from peptic origin. A multicentric controlled trial.
Basile M; Celi S; Parisi A; Castiglione N; Parisi S
Ital J Surg Sci; 1984; 14(1):31-5. PubMed ID: 6146586
[TBL] [Abstract][Full Text] [Related]
10. Somatostatin in the treatment of non-variceal upper gastrointestinal bleeding.
Jenkins SA; Poulianos G; Coraggio F; Rotondano G
Dig Dis; 1998; 16(4):214-24. PubMed ID: 9732181
[TBL] [Abstract][Full Text] [Related]
11. Effect of a somatostatin analogue, SMS 201-995, on 133Xe clearance from colonic mucosa in unanesthetized man.
Mortensen PE; Olsen J; Bousfield R; Agerskov K; Christiansen J
Scand J Gastroenterol; 1987 Nov; 22(9):1056-8. PubMed ID: 2892248
[TBL] [Abstract][Full Text] [Related]
12. Somatostatin in the treatment of severe upper gastrointestinal bleeding: a multicentre controlled trial.
Torres AJ; Landa I; Hernández F; Jover JM; Suárez A; Arias J; Cuberes R; Santoyo J; Fernández R; Calleja J
Br J Surg; 1986 Oct; 73(10):786-9. PubMed ID: 2876741
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of meal stimulated gastric acid secretion by an octapeptide somatostatin analogue SMS 201-995.
Olsen JA; Loud FB; Christiansen J
Gut; 1987 Apr; 28(4):464-7. PubMed ID: 2884171
[TBL] [Abstract][Full Text] [Related]
14. [Drug therapy and prevention of acute upper gastrointestinal hemorrhage].
Londong W
Z Gastroenterol; 1983 Jun; 21(6):282-9. PubMed ID: 6137116
[TBL] [Abstract][Full Text] [Related]
15. Somatostatin or octreotide compared with H2 antagonists and placebo in the management of acute nonvariceal upper gastrointestinal hemorrhage: a meta-analysis.
Imperiale TF; Birgisson S
Ann Intern Med; 1997 Dec; 127(12):1062-71. PubMed ID: 9412308
[TBL] [Abstract][Full Text] [Related]
16. The pharmacological therapy of non-variceal upper gastrointestinal bleeding.
Greenspoon J; Barkun A
Gastroenterol Clin North Am; 2010 Sep; 39(3):419-32. PubMed ID: 20951910
[TBL] [Abstract][Full Text] [Related]
17. Clinical, controlled trial of somatostatin with ranitidine and placebo in the control of peptic hemorrhage of the upper gastrointestinal tract.
Coraggio F; Bertini G; Catalano A; Scarpato P; Gualdieri L
Digestion; 1989; 43(4):190-5. PubMed ID: 2575550
[TBL] [Abstract][Full Text] [Related]
18. Somatostatin and ranitidine in the treatment of non-variceal upper gastrointestinal bleeding: a prospective, randomized, double-blind, controlled study.
Okan A; Simsek I; Akpinar H; Ellidokuz E; Sanul AR; Aksöz K
Hepatogastroenterology; 2000; 47(35):1325-7. PubMed ID: 11100343
[TBL] [Abstract][Full Text] [Related]
19. Somatostatin inhibits gastric acid secretion more effectively than pantoprazole in patients with peptic ulcer bleeding: a prospective, randomized, placebo-controlled trial.
Avgerinos A; Sgouros S; Viazis N; Vlachogiannakos J; Papaxoinis K; Bergele C; Sklavos P; Raptis SA
Scand J Gastroenterol; 2005 May; 40(5):515-22. PubMed ID: 16036503
[TBL] [Abstract][Full Text] [Related]
20. Somatostatin and cimetidine in peptic-ulcer haemorrhage. A randomised controlled trial.
Kayasseh L; Gyr K; Keller U; Stalder GA; Wall M
Lancet; 1980 Apr; 1(8173):844-6. PubMed ID: 6103209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
